Cytokines in multiple sclerosis: methodological aspects and pathogenic implications
- 1 October 2002
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 8 (5) , 396-404
Abstract
Multiple sclerosis (MS) is one of the leading causes of disability among young adults of Caucasian origin. One hundred and fifty years after the first description of the disease, the cause of MS remains unknown. Ironically, the few hypotheses concerning MS pathogenesis that are valid today were first proposed over a hundred years ago. However, equipped with the advanced technology of molecular biology and imaging systems, we are at present progressively uncovering clues to understanding the pathogenesis of the disease. It is clearly evident that aberrant immune responses occur in MS, and it is likely that the spectrum of cytokines produced decisively influences disease outcome. The detrimental consequences of IFN-γ and the beneficial effects of IFN-βtreatment in MS support this hypothesis. However, there are still major gaps in our knowledge of the involvement of cytokines in MS. Numerous studies have addressed the question of cytokine levels in MS, often with conflicting results; elevated, normal and decreased levels of almost all cytokines have been reported. This scenario most probably reflects methodological dilemmas as well as the complex biology of cytokines. Here we focus on possible reasons for the discrepancies of results reported on cytokines in MS and summarize findings obtained in particular by the application of enzyme-linked immunospot (ELISPOT) assays to cytokine studies in MS.Keywords
This publication has 76 references indexed in Scilit:
- Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies?Immunology Today, 1999
- Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?Multiple Sclerosis Journal, 1998
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Interleukin 6 and its Receptor: Ten Years LaterInternational Reviews of Immunology, 1998
- Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 CellsJournal of Experimental Medicine, 1997
- Mechanisms of Immune Injury in Multiple SclerosisBrain Pathology, 1996
- Interleukin‐10 functions as an antiinflammatory cytokine in rheumatoid synoviumArthritis & Rheumatism, 1996
- Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic MouseClinical Immunology and Immunopathology, 1994
- Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.Journal of Clinical Investigation, 1990
- EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERONThe Lancet, 1987